Israel’s 20th Biomed Conference will take place on May 10. Its organizers expect an even larger participation than in previous years. For the local med-tech and health-tech industries, the conference offers an excellent opportunity to showcase Israeli innovation.
Viz.ai, for example, announced on April 7 that it had raised over $100 million more, giving it an estimated value of $1.2 billion. This round of funding was led by two American venture capital funds, Tiger Global and Insight Partners.
